News
The race-based element of the research might have put it in the crosshairs of the White House's bid to defund diversity, ...
The heat advisory is in effect from 1 p.m. Friday to 7 p.m. Saturday. Here's some important safety reminders when it comes to ...
As of the week ending June 7, NB.1.8.1 is the second most dominant variant in the U.S., accounting for an estimated 37% of ...
Critics say Kennedy is ordering a review of childhood vaccines to stoke skepticism, risking the spread of disease.
New polling shows 50% of Americans disapprove of Health Secretary Robert F. Kennedy Jr.'s decisions regarding a key vaccine ...
Another batch of 900 arrived last week and some 900 more will soon make their way to the roughly 140-acre farm in Aquebogue, ...
The National Institutes of Health is undertaking an extended study of the health effects that East Palestine, Ohio, residents ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the ...
The new coronavirus variant surging in China has arrived in the US. Here’s what to know about Nimbus
A new Covid-19 variant called NB.1.8.1, or Nimbus, represents about a third of new US Covid-19 cases. Dr. Leana Wen answers ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained ...
A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results